Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

News Daily News

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

October 23, 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

ADAPT-DES at 2 Years Offers Insights Into Provider Strategies and Aspirin Monotherapy Beyond 1 Year

News Daily News

ADAPT-DES at 2 Years Offers Insights Into Provider Strategies and Aspirin Monotherapy Beyond 1 Year

Yael L. Maxwell

August 07, 2017

Elevated Cardiovascular Risk May Linger for Several Years After a Severe Infection

News Daily News

Elevated Cardiovascular Risk May Linger for Several Years After a Severe Infection

August 02, 2017

Plaque Progression Observed in Extreme Endurance Runners With Preexisting CAD

News Daily News

Plaque Progression Observed in Extreme Endurance Runners With Preexisting CAD

Michael O'Riordan

July 05, 2017

TCTMD’s Top 10 Most Popular Stories for June 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2017

July 03, 2017

CANTOS: Canakinumab Cuts MI, Stroke in Post-MI Patients With Elevated CRP

News Daily News

CANTOS: Canakinumab Cuts Combo of MI, Stroke, CV Death in Post-MI Patients With Elevated CRP

June 22, 2017

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

News Conference News EuroPCR 2017

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

Michael O'Riordan

May 16, 2017

Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women

News Daily News

Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women

May 11, 2017

Avoiding Gluten May Backfire in Terms of Coronary Risk in the General Population, Study Suggests

News Daily News

Avoiding Gluten May Backfire in Terms of Coronary Risk in the General Population, Study Suggests

May 11, 2017

News Industry News

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes

May 02, 2017

‘Constellation of Cardiovascular Stressors’ Puts Firefighters at Risk for MI

News Daily News

‘Constellation of Cardiovascular Stressors’ Puts Firefighters at Risk for MI

April 03, 2017

People Living in Amazon Rainforest Provide Clues to Coronary Protection

News Conference News ACC 2017

People Living in Amazon Rainforest Provide Clues to Coronary Protection

March 17, 2017

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

News Daily News

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

Yael L. Maxwell

March 03, 2017

Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients

News Daily News

Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients

Michael O'Riordan

February 03, 2017

E-Cigarettes May Increase CV Disease Risk Just Like the Real Thing

News Daily News

E-Cigarettes May Increase CV Disease Risk Just Like the Real Thing

February 03, 2017

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

News Daily News

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

Michael O'Riordan

February 02, 2017

News Features

Be It Resolved: As Evidence Mounts in Favor of a Brain-Heart Connection, Stress Should Be on the Radar During CVD Diagnosis

Yael L. Maxwell

January 16, 2017

News Daily News

HIV-Positive Patients Face Elevated Rate of Type 2 MI

January 12, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.